Results
eNauka >
Results >
Efficacy, Pharmacodynamics, and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rheumatoid Arthritis Results of Two Randomized, Double-Blind, Placebo-Controlled Clinical Studies
| Title: | Efficacy, Pharmacodynamics, and Safety of VX-702, a Novel p38 MAPK Inhibitor, in Rheumatoid Arthritis Results of Two Randomized, Double-Blind, Placebo-Controlled Clinical Studies | Authors: | Damjanov, Nemanja S; Kauffman, Robert S; Spencer-Green, George T | Issue Date: | 2009 | Publication: | ARTHRITIS AND RHEUMATISM | ISSN: | 0004-3591 Arthritis and Rheumatism Search Idenfier |
Type: | Article | Collation: | vol. 60 br. 5 str. 1232-1241 | DOI: | 10.1002/art.24485 | WoS-ID: | 000266071700004 | Scopus-ID: | 2-s2.0-66049086274 | URI: | https://enauka.gov.rs/handle/123456789/803956 | Project: | Vertex Pharmaceuticals, Inc | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.